Avapritinib is a selective kinase inhibitor that targets specific KIT and PDGFRA mutations, utilized primarily in the treatment of patients with unresectable or metastatic gastrointestinal stromal tumors… Read more
![Chemical structure of (2-(4-(6-(4-Fluorophenyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)(phenyl)methanone](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1703795-41-8-2-4-6-4-Fluorophenylpyrrolo21-f124triazin-4-ylpiperazin-1-ylpyrimidin-5-ylphenylmethanone.png&w=3840&q=75)
![Chemical structure of (R)-(4-Fluorophenyl)(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)methanol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1703793-18-3-R-4-Fluorophenyl2-4-6-1-methyl-1H-pyrazol-4-ylpyrrolo21-f124triazin-4-ylpiperazin-1-ylpyrimidin-5-ylmethanol.png&w=3840&q=75)
![Chemical structure of (S)-1-(2-(4-(6-Bromopyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)-1-(4-fluorophenyl)ethan-1-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2505078-30-6-S-1-2-4-6-Bromopyrrolo21-f124triazin-4-ylpiperazin-1-ylpyrimidin-5-yl-1-4-fluorophenylethan-1-amine.png&w=3840&q=75)
![Chemical structure of 4-(4-(5-(1-(4-Fluorophenyl)vinyl)pyrimidin-2-yl)piperazin-1-yl)-6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1703793-09-2-4-4-5-1-4-Fluorophenylvinylpyrimidin-2-ylpiperazin-1-yl-6-1-methyl-1H-pyrazol-4-ylpyrrolo21-f124triazine.png&w=3840&q=75)
![Chemical structure of 4-(4-(5-(2-(4-Fluorophenyl)propan-2-yl)pyrimidin-2-yl)piperazin-1-yl)-7-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a][1,3,5]triazine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1703793-31-0-4-4-5-2-4-Fluorophenylpropan-2-ylpyrimidin-2-ylpiperazin-1-yl-7-1-methyl-1H-pyrazol-4-ylpyrazolo15-a135triazine.png&w=3840&q=75)
![Chemical structure of 6-(1-Methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4(1H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1703794-32-4-6-1-Methyl-1H-pyrazol-4-ylpyrrolo21-f124triazin-41H-one.png&w=3840&q=75)
















Avapritinib is a selective kinase inhibitor that targets specific KIT and PDGFRA mutations, utilized primarily in the treatment of patients with unresectable or metastatic gastrointestinal stromal tumors (GIST). As an essential resource for analytical laboratories, this category provides reference standards of Avapritinib, along with a comprehensive selection of related synthesis impurities, metabolites, and stable isotope labelled compounds. Pharmaceutical researchers utilize these materials for accurate impurity profiling and to validate analytical methods for rigorous quality control processes. Stable isotope labelled analogues serve as critical internal standards in mass spectrometry workflows, ensuring precise quantification during stability studies and pharmacokinetic analysis. By providing access to both pharmacopeial and non-pharmacopeial impurities, as well as the parent drug, this collection supports the development and analytical testing required to maintain safety and compliance standards in drug formulation.